Busulfex Injection (Busulfan): The Essential Conditioning Agent for Bone Marrow Transplant – Global Supply by Ernest Oncology
In the field of hematology and transplant medicine, Busulfex Injection (containing the active ingredient Busulfan) is a vital therapeutic agent. As a potent bifunctional alkylating agent, Busulfex is globally recognized for its role in "conditioning" or "myelopreparative" regimens. It is used to clear the patient's existing bone marrow to make way for healthy new cells during a Hematopoietic Stem Cell Transplant (HSCT).
Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a trusted Exporter, Bulk Supplier, and Distributor from India. We facilitate the secure, GMP-compliant international distribution of Busulfex Injection to the UK (London), USA, Abu Dhabi (UAE), Australia, and South Africa via specialized temperature-controlled pharmaceutical logistics.
What is Busulfex Injection? (The Busulfan Mechanism)
Busulfex is a sterile solution for intravenous infusion containing Busulfan (available as 60 mg / 10 mL Vials). Unlike oral busulfan, the intravenous Busulfex formulation provides 100% bioavailability and highly predictable pharmacokinetics, which is critical for achieving the precise dosing required for successful engraftment without excessive toxicity.
Primary Therapeutic Indications
Conditioning for HSCT: Used in combination with Cyclophosphamide or Fludarabine as a preparatory regimen prior to allogeneic hematopoietic progenitor cell transplantation for Chronic Myelogenous Leukemia (CML).
Pediatric Conditioning: Utilized in conditioning regimens for children undergoing bone marrow transplants for various malignant and non-malignant conditions.
Advanced Hematologic Disorders: Often utilized in high-dose therapy protocols for other leukemias and lymphomas requiring stem cell rescue.
| Feature | Technical Specification |
| Brand Name | Busulfex |
| Active Ingredient | Busulfan |
| Pharmacological Class | Alkylating Agent (Methanesulfonate) |
| Available Strength | 60 mg per 10 mL Vial |
| Manufacturer | Otsuka / Leading Global Oncology MNCs |
| Form | Concentrated Solution for Infusion |
| Storage | Refrigerate at 2°C to 8°C; Do not freeze |
Mechanism of Action: DNA Cross-Linking
Busulfex exerts its powerful cytotoxic effect through the alkylation of DNA:
Alkylation Process: Busulfan reacts with the N7 position of guanine, creating DNA-DNA cross-links.
Myelosuppression: This specific action targets the primitive hematopoietic stem cells, effectively "cleaning" the marrow space.
Engraftment Preparation: By suppressing the host's immune system and marrow, Busulfex ensures that the donor's healthy stem cells can successfully colonize the bone marrow.
Administration & Clinical Safety
Dilution Required: Busulfex must be diluted with 0.9% Sodium Chloride or 5% Dextrose prior to infusion.
Precise Dosing: Dosing is frequently calculated based on Ideal Body Weight (IBW) or Actual Body Weight, often requiring Therapeutic Drug Monitoring (TDM) to avoid Hepatic Veno-Occlusive Disease (VOD).
Seizure Prophylaxis: Because Busulfan crosses the blood-brain barrier, prophylactic anticonvulsant therapy (like Phenytoin) is usually administered concurrently.
Cold Chain Maintenance: Strict 2°C to 8°C refrigeration is mandatory throughout the supply chain to ensure product integrity.
Global Reach: Exporting to UK, USA, UAE, Australia, and South Africa
Ernest Oncology excels in the specialized logistics required for cold-chain, high-value oncology medicines. We ensure that your supply—sourced through verified international channels—reaches our global partners through secure and legal supply chains.
United Kingdom & London: Supporting NHS transplant centers and private hematology hospitals in London and across the UK.
United States: Providing reliable supply for specialized pharmacies, hospital systems, and clinical research centers.
Abu Dhabi & UAE: Fast-tracked export to the Middle East’s leading cancer care facilities and medical hubs.
Australia & South Africa: Reliable bulk supply for government health departments and regional pharmaceutical distributors.
📞 Contact Ernest Oncology — Pharmaceutical Exporter from India
(Group of Ernest Pharmaceutical Pvt. Ltd.)
Partner with a verified leader in the international supply of specialty oncology and life-saving medicines.
🌐 Websites:
📧 Email:
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 93599 02383
🔗 Instant Chat:
